SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.130+0.9%Jan 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (10193)5/8/2018 12:36:25 PM
From: BoredMember  Read Replies (2) of 12873
 
Again, I must say that you are using the stock price and shareholder return as your measure of success. That is not what I believe Dr. Anil Diwan is measuring success by.

If Nanoviricides is the primary source of revenue for Theracour as you profess, then surely Nonoviricides is extremely important to Theracour and Dr. Anil Diwan.

Isn't that abundantly clear?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext